Track topics on Twitter Track topics that are important to you
The global healthcare contract research and manufacturing outsourcing market is expected to post a CAGR of close to 12% over the period 2018-2022, according to the latest market research report by Technavio.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180614005785/en/
Technavio has published a new market research report on the global healthcare contract research and manufacturing outsourcing market from 2018-2022. (Graphic: Business Wire)
A key factor driving the market’s growth is the rising focus on drug discovery and development. Pharmaceutical and biotechnology companies, as well as research institutes worldwide, are increasingly investing in R&D for drug discovery and development, owing to the rise in prevalence of chronic diseases.
This market research report on the global healthcare contract research and manufacturing outsourcing marketalsoprovides an analysis of the most important trends expected to impact the market outlook during the forecast period. Technavio predicts an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
In this report, Technavio highlights the growth in the number of M&As as one of the key emerging trends in the global healthcare contract research and manufacturing outsourcing market:
Global healthcare contract research and manufacturing outsourcing market: growth in the number of M&As
A significant number of medical devices and pharmaceutical and biotechnology companies have reduced their R&D and operation budgets, which has increased the demand for outsourcing drug discovery and medical device development. Moreover, companies have consolidated their infrastructure in response to the global economic meltdown, poor prospects of growth in revenue, and expensive and inefficient operations. Strategic partnerships between pharmaceutical companies and CROs have resulted in the reduction of spending on manufacturing.
“Vendors in the market have adopted M&A as one of the main marketing strategies to broaden their portfolio, access new geographies, and consolidate their core business in existing as well as new markets. This strategy has resulted in an increase in inorganic growth for companies, especially the large players. These entities pursue M&A with the long term objective of establishing their presence in new markets,” says a senior analyst at Technavio.
Global healthcare contract research and manufacturing outsourcing market: Segmentation analysis
This market research report segments the global healthcare contract research and manufacturing outsourcing market by application (drug discovery and outsourcing, medical device manufacturing outsourcing) and key regions (the Americas, APAC, and EMEA).
The Americas held the highest share of the global healthcare contract research and manufacturing outsourcing market in 2017, accounting for a market share of around 43%, followed by EMEA and APAC. Although APAC held the smallest share of the market, it is expected to witness the maximum increase in its market share over the forecast period. The market share of this region will witness a significant increase of over 4% while the other two regions will see a decline in their share of the market.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Five Forces Analysis
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at email@example.com.
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Bioscience - any of the sciences that deal with living organisms. The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...